Data on Solid Cancer Reported by Researchers at King's College London (Short-term and medium-term survival of critically ill patients with solid tumours admitted to the intensive care unit: a retrospective analysis)
By a News Reporter-Staff News Editor at Clinical Oncology Week Data detailed on Oncology - Solid Cancer have been presented. According to news originating from London, United Kingdom, by NewsRx correspondents, research stated, "Patients with cancer frequently require unplanned admission to the intensive care unit (ICU). Our objectives were to assess hospital and 180-day mortality in patients with a non-haematological malignancy and unplanned ICU admission and to identify which factors present on admission were the best predictors of mortality."
Our news journalists obtained a quote from the research from King's College London, "Retrospective review of all patients with a diagnosis of solid tumours following unplanned admission to the ICU between 1 August 2008 and 31 July 2012. Single centre tertiary care hospital in London (UK). 300 adult patients with non-haematological solid tumours requiring unplanned admission to the ICU. None. Hospital and 180-day survival. 300 patients were admitted to the ICU (median age 66.5 years; 61.7% men). Survival to hospital discharge and 180 days were 69% and 47.8%, respectively. Greater number of failed organ systems on admission was associated with significantly worse hospital survival (p <0.001) but not with 180-day survival (p=0.24). In multivariate analysis, predictors of hospital mortality were the presence of metastases (OR 1.97, 95% CI 1.08 to 3.59), Acute Physiology and Chronic Health Evaluation II (APACHE II) Score (OR 1.07, 95% CI 1.01 to 1.13) and a Glasgow Coma Scale Score <7 on admission to ICU (OR 5.21, 95% CI 1.65 to 16.43). Predictors of worse 180-day survival were the presence of metastases (OR 2.82, 95% CI 1.57 to 5.06), APACHE II Score (OR 1.07, 95% CI 1.01 to 1.13) and sepsis (OR 1.92, 95% CI 1.09 to 3.38)."
According to the news editors, the research concluded: "Short-term and medium-term survival in patients with solid tumours admitted to ICU is better than previously reported, suggesting that the presence of cancer alone should not be a barrier to ICU admission."
For more information on this research see: Short-term and medium-term survival of critically ill patients with solid tumours admitted to the intensive care unit: a retrospective analysis. Bmj Open, 2016;6(10):e011363. (BMJ Publishing Group - group.bmj.com/; Bmj Open - bmjopen.bmj.com/)
The news correspondents report that additional information may be obtained from R. Fisher, Dept. of Critical Care, King's College London, Guy's & St Thomas' Hospital NHS Foundation Trust, London, UK. Additional authors for this research include C. Dangoisse, S. Crichton, C. Whiteley, L. Camporota, R. Beale and M. Ostermann (see also Oncology - Solid Cancer).
Keywords for this news article include: London, Europe, Hospital, Oncology, Solid Cancer, United Kingdom.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC